Obligate overdiagnosis rates of mammographic screenings are strongly dependent on a women's age at the time of the noninvasive breast exam, according to a study recently published in Radiology.

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) have published new breast cancer screening guidelines, once again recommending that all women begin annual screening at age 40.

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) released updated breast cancer screening guidelines, April 4—the first to recognize black women face higher risks for the disease and should be screened accordingly.

In 2009, the U.S. Preventative Services Task Force (USPSTF) revised its breast cancer screening guidelines. These changes may be one reason for a continuous decline in breast screening exams in the U.S. since 2010, according to results of a study published by the American Journal of Roentgenology.

Researchers from Duke University Medical Center have found that women with greater than minimal background parenchymal enhancement (BPE) at an index MRI face increased risk of developing breast cancer, according to a study published online March 27 in Academic Radiology.

A Pennsylvania woman was shocked when quoted $351 for a breast MRI from the Crozer-Keystone Health System, before being billed $4,650 for the exam.  

FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging solutions, has submitted to the U.S. Food and Drug Administration (FDA) the first module of its premarket approval (PMA) application for digital breast tomosynthesis* (DBT), as an optional upgrade for the Aspire Cristalle mammography system.